Home » Topics » Regulatory » Patents

Patents
RSS

Nitric oxide synthase inhibitors from Merck & Co.

Aug. 23, 1996

BASF reveals NMDA and AMPA antagonists

Aug. 23, 1996

5-HT1D antagonists claimed by SmithKine Beecham

Aug. 23, 1996

Allelix describes dopamine D4 ligands for schizophrenia

Aug. 23, 1996

Allelix Biopharmaceuticals reports selective M1/M2 receptor ligands

Aug. 23, 1996

Ciba-Geigy describes oligonucleotide diagnostic agents

Aug. 23, 1996

Organobismuth derivative contrast agent from Nissan Chemical

Aug. 23, 1996

Hematopoiesis-stimulating compounds from Nycomed Pharma

Aug. 23, 1996

New hypolipidemic agent from Schering-Plough

Aug. 23, 1996

Yamanouchi and PT CarbaPharma describe cathepsin L inhibitor

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...